Portage Biotech Inc.

NASDAQ:PRTG

6.2 (USD) • At close July 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 000000000000.0980000.0420.2410.6451.5930.31100.010.0420.0760.02500
Cost of Revenue 0.0540.001000000000.04100.049000.0330.00101.662000000.95700
Gross Profit -0.054-0.00100000000-0.0410.181-0.049000.0060.2410.6451.5930.31100.010.0420.076-0.93200
Gross Profit Ratio 000000000001.8350000.14911110111-37.76300
Reseach & Development Expenses 12.5358.2146.7697.3124.1080.7620.56132.454.5772.9291.1360.032000000000000000
General & Administrative Expenses 5.6648.3618.8195.1281.871.8681.552.5574.5161.2971.6531.5581.5682.3542.4750.5780.6120000000000
Selling & Marketing Expenses 00000000000.01400.0320.1360.0850.0530.1170000000000
SG&A 5.6648.3618.8195.1281.871.8681.552.5574.5161.2971.6171.5581.62.492.560.6310.7290.6752.24.361.0710.2270.6880.4180.010.0130.046
Other Expenses 00.0010000.1340.1160.4840.0950.0910-0.0520.0870.9970.719-0.095-0.0010.00400000.0230.0220.0150.3040.344
Operating Expenses 18.19916.57615.58812.445.9782.7642.22735.4919.1884.3172.7521.5381.6873.4873.2790.5360.7280.6782.24.361.0710.2270.7110.440.0250.3160.39
Operating Income -18.253-16.575-15.588-12.44-5.978-2.764-2.227-35.491-9.188-4.317-2.634-1.357-1.612-3.889-3.175-0.544-0.487-0.033-3.934-4.048-1.071-0.217-0.669-0.364-0.957-0.317-0.397
Operating Income Ratio 00000000000-13.789000-12.979-2.019-0.052-2.47-12.9970-20.84-15.965-4.783-38.77400
Total Other Income Expenses Net -67.444-105.9470.771-2.452-0.531-0.83125.97634.858-0.007-0.116-3.993-0.113-0.8750-0.2460-0.0670.4600.3110.0360.009-0.1610000
Income Before Tax -85.697-122.522-14.817-14.892-6.527-3.594123.741-0.641-9.195-4.341-6.627-1.47-2.487-3.718-3.421-0.612-0.4870.427-4.007-3.718-1.035-0.217-0.669-0.364-0.95700
Income Before Tax Ratio 00000000000-14.935000-14.607-2.0190.662-2.515-11.9370-20.84-15.965-4.783-38.77400
Income Tax Expense -10.548-17.8564.3522.2970.74-0.2170-52.3420-1.2190.0030.0020.002-0.0530.6780.0520.0680.5690.1670.129-0.0360.0010.1670.725000.007
Net Income -75.339-104.611-16.87-15.833-5.333-2.635123.74116.299-5.706-3.118-6.305-1.47-2.476-3.836-3.853-0.546-0.556-0.144-2.511-4.18-1.038-0.218-0.836-1.09-0.957-0.317-0.397
Net Income Ratio 00000000000-14.937000-13.023-2.301-0.224-1.576-13.420-20.935-19.937-14.31-38.77400
EPS -3.7-6.49-1.29-1.35-9.74-0.55924.146.42-2.38-1.61-3.52-1.8-3.15-4.89-8.97-1.81-1.931.84-15.91-35.55-28.31-21.08-118.28-168.85-3,312.31-103.87-251.36
EPS Diluted -3.7-6.49-1.29-1.35-9.74-0.55917.8120-2.38-1.61-3.52-1.8-3.15-4.89-8.97-1.81-1.931.84-15.91-35.55-28.31-21.08-118.28-168.85-3,312.31-103.87-251.36
EBITDA -18.199-15.775-15.588-14.186-5.949-0.65-2.067-35.331-0-4.317-6.625-1.468-2.485-3.711-3.296-0.493-0.553-0.49-2.341-4.013-1.04-0.217-0.646-0.342-0.942-0.304-0.378
EBITDA Ratio 00000000000-14.917000-11.75-2.292-0.76-1.47-12.8840-20.84-15.415-4.492-38.17600